ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 84 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $119 | -99.9% | 319,516 | -11.0% | 0.00% | – |
| Q3 2022 | $179,000 | +68.9% | 358,869 | +97.8% | 0.00% | – |
| Q2 2022 | $106,000 | -43.9% | 181,459 | +26.9% | 0.00% | – |
| Q4 2021 | $189,000 | -80.0% | 142,992 | -65.3% | 0.00% | -100.0% |
| Q3 2021 | $947,000 | +866.3% | 411,713 | +1740.2% | 0.00% | – |
| Q2 2021 | $98,000 | -95.6% | 22,373 | -92.6% | 0.00% | -100.0% |
| Q1 2021 | $2,204,000 | +242.2% | 303,524 | +103.5% | 0.00% | – |
| Q4 2020 | $644,000 | -56.8% | 149,162 | -58.9% | 0.00% | -100.0% |
| Q3 2020 | $1,492,000 | +13.0% | 362,998 | +65.0% | 0.00% | 0.0% |
| Q2 2020 | $1,320,000 | +23.2% | 220,033 | +182.4% | 0.00% | +100.0% |
| Q4 2019 | $1,071,000 | -76.5% | 77,919 | -79.7% | 0.00% | -85.7% |
| Q3 2019 | $4,554,000 | -27.9% | 383,398 | -15.1% | 0.01% | -22.2% |
| Q2 2019 | $6,318,000 | +28.9% | 451,634 | +64.7% | 0.01% | +28.6% |
| Q1 2019 | $4,903,000 | +7.7% | 274,211 | -5.3% | 0.01% | 0.0% |
| Q4 2018 | $4,554,000 | – | 289,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |